Ninepoint Partners’s Hologic HOLX Stock Holding History

Ninepoint Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,863	Closed	-$427K	–	86
2020 Q4	$427K	Buy	+5,863	New	+$414K	0.17%	48

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Ninepoint Partners's HOLX Position: Q1 2021 in Review

Ninepoint Partners sold out of Hologic (HOLX) in Q1 2021, closing a stake of 5,863 shares — an estimated $427K sold.

Ninepoint Partners first reported a position in HOLX in Q4 2020 and held it in 1 quarter. The position peaked at $427K in Q4 2020. 637 funds tracked by Wall St. Rank hold HOLX as of Q1 2021.

Ninepoint Partners reported no remaining Hologic position as of Q1 2021 after selling out during the quarter.
Ninepoint Partners sold 5,863 Hologic shares in Q1 2021, an estimated $427K.
Ninepoint Partners first reported a position in Hologic in Q4 2020 and held it in 1 quarter.
Ninepoint Partners's Hologic position peaked at $427K in Q4 2020.
637 funds tracked by Wall St. Rank held Hologic as of Q1 2021.

Based on Ninepoint Partners's 13F filing for Q1 2021, filed 7 May 2021.